Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial.
Authors: Gögenur M; Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark., Rosen AW; Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark., Iveson T; Southampton University, Southampton, United Kingdom., Kerr RS; Department of Oncology, University of Oxford, Oxford, United Kingdom., Saunders MP; The Christie Hospital, Manchester, United Kingdom., Cassidy J; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain., Haydon A; Australasian Gastro-Intestinal Trials Group, Sydney, Australia., Glimelius B; Department of Immunology, Genetics and Pathology, University of Uppsala, Uppsala, Sweden., Harkin A; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Allan K; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Pearson S; Oncology Clinical Trials Office, Department of Oncology, University of Oxford, Oxford, United Kingdom., Boyd KA; School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom., Briggs AH; School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.; London School of Hygiene and Tropical Medicine, London, United Kingdom., Waterston A; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Medley L; Royal United Hospital, Bath, United Kingdom., Ellis R; Royal Cornwall Hospitals, National Health Service Trust, Cornwall, United Kingdom., Dhadda AS; Castle Hill Hospital, Hull, United Kingdom., Harrison M; Mount Vernon Cancer Centre, Northwood, United Kingdom., Falk S; Bristol Cancer Institute, Bristol, United Kingdom., Rees C; Southampton University, Southampton, United Kingdom., Olesen RK; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Propper D; Southampton University, Southampton, United Kingdom.; Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom., Bridgewater J; University College London, London, United Kingdom., Azzabi A; Newcastle upon Tyne Hospitals, National Health Service Foundation Trust, Newcastle, United Kingdom., Cunningham D; Brighton and Sussex University Hospital Trust, Brighton, United Kingdom., Hickish T; University Hospitals Dorset, Bournemouth University, Bournemouth, United Kingdom., Gollins S; North Wales Cancer Treatment Centre, Rhyl, United Kingdom., Wasan HS; Hammersmith Hospital, Imperial College London, London, United Kingdom., Kelly C; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Gögenur I; Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark.; Danish Colorectal Cancer Group, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Holländer NH; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Køge, Denmark.
Source: JAMA surgery [JAMA Surg] 2024 Aug 01; Vol. 159 (8), pp. 865-871.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Equivalence Trial
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589553 Publication Model: Print Cited Medium: Internet ISSN: 2168-6262 (Electronic) Linking ISSN: 21686254 NLM ISO Abbreviation: JAMA Surg Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6262
DOI:10.1001/jamasurg.2024.1555